您的购物车当前为空
别名 米巴伐单抗
Mibavademab 是一种在中华仓鼠卵巢(CHO)细胞中表达的重组人源化单克隆抗体,特异性靶向LEPR/CD29受体。Mibavademab由人源IgG4SP铰链稳定重链和人源κ轻链组成,预测分子量为145.58 kDa,可用于治疗先天性瘦素缺乏的相关研究。

为众多的药物研发团队赋能,
让新药发现更简单!
Mibavademab 是一种在中华仓鼠卵巢(CHO)细胞中表达的重组人源化单克隆抗体,特异性靶向LEPR/CD29受体。Mibavademab由人源IgG4SP铰链稳定重链和人源κ轻链组成,预测分子量为145.58 kDa,可用于治疗先天性瘦素缺乏的相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In stock | |
| 5 mg | ¥ 5,860 | In stock | |
| 10 mg | ¥ 7,890 | In stock | |
| 25 mg | ¥ 11,700 | In stock | |
| 50 mg | ¥ 15,800 | In stock |
Mibavademab 相关产品
| 产品描述 | Mibavademab is a recombinant humanized monoclonal antibody expressed in Chinese Hamster Ovary (CHO) cells that specifically targets the leptin receptor (LEPR/CD295). Mibavademab is composed of a human IgG4SP hinge-stabilized heavy chain and a human kappa (huκ) light chain, possesses a predicted molecular weight of 145.58 kDa. Mibavademab can be used in studies about the treatment of congenital leptin deficiency. |
| 别名 | 米巴伐单抗 |
| CAS No. | 2305770-44-7 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
评论内容